XBridge® and ACQUITY UPLC® Oligonucleotide C18 Columns for Synthetic Oligonucleotide Analysis and PurificationIon-pair, reversed-phase separation of detritylated oligonucleotides on sub-3 micron particles yields exceptional component resolution.UPLC ® technology increases sample throughput while maintaining necessary oligonucleotide component resolution.LC/UV and LC/MS methods for enhanced quantitative and qualitative oligonuc…
ACQUITY UPLC® HSS (High Strength Silica) T3 Columns contain the first and only 100% silica particle designed, tested and intended for use in applications up to 15000 psi/1000 bar. The ACQUITY UPLC® HSS particle is not an HPLC particle. High pore volume HPLC particles do not possess the mechanical stability necessary to withstand the high column packing and operating pressures of UPLC® separations. The first ligand chemistry in…
Developing differentiated polymers and deploying a sustainable operation are two of the utmost challenges facing the polymer and plastics industries. Current GPC/SEC methods are limited by a lack of resolution for novel and complex polymeric entities, the time required to achieve satisfactory separation, and the volume of solvent consumed per analysis. Waters® ACQUITY® Advanced Polymer Chromatography™ (APC™) System is a breakt…
Accurately quantify trace analytes in a clinical diagnostic lab with the MassTrak ACQUITY UPLC I-Class PLUS/Xevo TQ-XS IVD System.
Developed for your most demanding LC/MS/MS quantitative applications, the Quattro Premier™ XE tandem quadrupole mass spectrometer features the highest levels of sensitivity, selectivity, robustness, speed and accuracy. To maximize the analytical advantages of your ACQUITY UPLC® System, the Quattro Premier XE operates at the highest data acquisition rates. Together, the ACQUITY UPLC® System and the Quattro Premier XE give you i…
The company’s most significant advance in chromatography since UPLC aims to accelerate scientific research and development
The ACQUITY UPLC H-Class PLUS Binary System accommodates challenging gradients, providing an increase in robust method throughput when used with BSM PLUS
Novel column technology designed to put disease research and drug development on a more productive and efficient path
